Not always under the flag of Fitzroy.be, but over the past 10+ years a lot of references have been built — in the following industry segments: Healthcare & Life Sciences (Medical Devices & Diagnostics, Consumer- & Animal Health and Pharma & Biotechnology), Financial Services (Banking and Insurance), Automotive and Logistics & Supply Chain.
References below are a non-exhaustive list, but definitely worth mentioning:
Crosspoint Solutions is part of the Cronos Group and a cluster of innovative IT services companies that are dedicated to harnessing data, customer and artificial intelligence to transform businesses. As one of Belgium’s largest incubators, they host more than 50 centers of expertise that show how to deploy hybrid intelligence technologies to achieve competitive differentiation.
Caring for the world, one person at a time… inspires and unites the people of Johnson & Johnson. They embrace research and science — bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
Lilly is a global health care leader that unites caring with discovery to make life better for people around the world. For more than a century, they have stayed true to a core set of values — excellence, integrity, and respect for people — that guide them in all they do: discovering medicines that meet real needs, improving the understanding and management of disease, and giving back to communities through philanthropy and volunteerism.
Galapagos is a pioneering biotechnology company, developing innovative medicines that will improve people’s lives. Their unique target discovery platform is transforming how medicines are discovered. A no fear of failure culture fuels their ambition to explore uncharted territory. At Galapagos, they are relentless in their drive to search for medicines with new modes of action that address high unmet patient needs. They focus on developing medicines which change the course of the disease, rather than just treat the symptoms. That is their promise to patients.